Zoetis (ZTS) Enterprise Value (2012 - 2026)
Zoetis (ZTS) posted quarterly Enterprise Value of -$1.9 billion for Q1 2026, down 12.78% year-over-year from -$2.2 billion in Q1 2025, and up 20.78% quarter-over-quarter from -$2.4 billion in Q4 2025.
Zoetis (ZTS) Enterprise Value (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Enterprise Value for 15 consecutive years, with -$1.9 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value fell 12.78% year-over-year to -$1.9 billion; the TTM figure through Mar 2026 stood at -$1.9 billion (down 12.78% YoY), while the FY2025 annual figure was -$2.4 billion, down 23.3% from the prior year.
- Enterprise Value improved to -$1.9 billion in Q1 2026 per ZTS's latest filing, from -$2.4 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$1.4 billion in Q2 2025 and bottomed at -$3.6 billion in Q4 2022.
- Historically, Enterprise Value has averaged -$2.1 billion across 5 years, with a median of -$2.0 billion in 2024.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 42.87% — and 2025, when it dropped 23.3%.
- Zoetis' Enterprise Value stood at -$3.6 billion in 2022, then surged by 42.87% to -$2.0 billion in 2023, then climbed by 2.93% to -$2.0 billion in 2024, then decreased by 23.3% to -$2.4 billion in 2025, then increased by 20.78% to -$1.9 billion in 2026.
- Business Quant data shows ZTS's Enterprise Value at -$1.9 billion in Q1 2026, -$2.4 billion in Q4 2025, and -$2.1 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | -164.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | -656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.68 Bn |
| Mar 31, 2026 | -1.94 Bn |
| Dec 31, 2025 | -2.45 Bn |
| Sep 30, 2025 | -2.08 Bn |
| Jun 30, 2025 | -1.44 Bn |
| Mar 31, 2025 | -1.72 Bn |
| Dec 31, 2024 | -1.99 Bn |
| Sep 30, 2024 | -1.71 Bn |
| Jun 30, 2024 | -1.58 Bn |
| Mar 31, 2024 | -1.98 Bn |
| Dec 31, 2023 | -2.05 Bn |
| Sep 30, 2023 | -1.76 Bn |
| Jun 30, 2023 | -1.72 Bn |
| Mar 31, 2023 | -2.11 Bn |
| Dec 31, 2022 | -3.58 Bn |
| Sep 30, 2022 | -2.51 Bn |
| Jun 30, 2022 | -2.65 Bn |
| Mar 31, 2022 | -3.14 Bn |
| Dec 31, 2021 | -3.48 Bn |
| Sep 30, 2021 | -3.27 Bn |